• Bone Morphogenetic Protein Receptor Type II (BMPR2) Gene Mutation Analysis
  • Glucose, Random, Urine
  • Tissue Transglutaminase (tTG) Antibody, IgA, IgG
  • Ova and Parasites, Stool
  • Hepatitis C Virus (HCV) NS3/4A Protease Inhibitor Resistance, GenoSure
  • Noonan Spectrum Disorders Gene Mutation Panel, NGS
  • Antidiuretic Hormone, Serum
  • Biopsy, Kidney
  • HLA-B75 (HLA-B*15:02) Genotyping for Carbamazepine Hypersensitivity
  • Gentamicin, Peak, Serum
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Prolyl Hydroxylase Domain-2 (PHD2/EGLN1) Gene Mutation Analysis
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References

Prolyl Hydroxylase Domain-2 (PHD2/EGLN1) Gene Mutation Analysis
Medical Test

Reference Ranges
Access to Prolyl Hydroxylase Domain-2 (PHD2/EGLN1) Gene Mutation Analysis is restricted.